ArticleFrontiers in immunology2026

Control of breast cancer patient-derived xenografts by CD70-targeted HIT-CAR T cells.

Pieter L Lindenbergh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.